Publication date: Jun 25, 2025
Background/Objectives: Children with sickle cell disease (SCD) often experience limited access to care, contributing to poor health outcomes. Patient-level predictors and outcomes associated with telehealth use among Medicaid-enrolled children with SCD remain unknown. This study aims to (1) analyze telehealth trends before and during the pandemic (March 2020-March 2022), (2) identify patient-level predictors of telehealth use, (3) assess its association with care continuity and health outcomes, and (4) identify physician specialties involved in telehealth visits. Methods: Using Texas Medicaid claims (March 2017-March 2022), we conducted a retrospective analysis of children aged 1-18 with ≥3 SCD-related claims. Monthly trends in outpatient visits (in-person and telehealth) were visualized from March 2019 to March 2022. Multivariable regression models examined predictors of telehealth use and associations with ≥10 hydroxyurea fills, emergency department (ED) visits, and hospitalizations, adjusting for age, sex, regions with SCD clinics, and prior healthcare utilization. Results: Among 903 included patients (mean [SD] age = 10. 4 [4. 1], 52. 6% male), 59. 4% had ≥1 telehealth visits between March 2019 and March 2022. Telehealth use peaked between March 2020 and May 2020, then gradually declined. Children with ≥10 SCD-related outpatient visits 1 year before the lockdown (March 2019-February 2020) had 77. 4% higher odds of using telehealth compared to those with 0-4 visits (OR = 1. 774, 95% CI = 1. 281-2. 457, p = 0. 0006), while controlling for sociodemographic characteristics. However, SCD-related telehealth use during the pandemic was not associated with either ≥10 hydroxyurea fills or reduced ED visits. Prior healthcare utilization remained a strong predictor of both outcomes. The majority of telehealth visits were conducted at multispecialty clinics (74%). Conclusions: Telehealth use surged early in the pandemic but later declined among Texas Medicaid-enrolled children with SCD. Children with high healthcare needs adopted telehealth, but this did not impact care continuity or extensive healthcare utilization. While maintaining telehealth access, other measures should be implemented to improve access and outcomes for this vulnerable population.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Basel | children |
| Outpatient | COVID-19 |
| Texas | Medicaid |
| sickle cell disease | |
| telehealth |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Sickle Cell Disease |
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | access to care |
| drug | DRUGBANK | Hydroxyurea |
| disease | MESH | emergency |
| disease | IDO | blood |
| disease | MESH | genetic disorder |
| disease | MESH | complications |
| disease | MESH | stroke |
| disease | MESH | chronic pain |
| disease | IDO | symptom |
| drug | DRUGBANK | Isoxaflutole |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | IDO | healthcare facility |
| drug | DRUGBANK | Sodium lauryl sulfate |
| drug | DRUGBANK | Methionine |
| drug | DRUGBANK | Serine |